Biogenix USA Decadrol capsules, packaged in plastic bottles with 90 capsules per bottle and also packaged as a bulk product in clear plastic bags.

Mira Health Products LTD. recalled Biogenix USA Decadrol capsules, packaged in plastic bottles with 90 capsules per bottle and also packaged as a bulk product in clear plastic in a Class II action, the FDA tier for products that may cause temporary or medically reversible health effects on Sep 4, 2013.

The FDA listed the reason as an undeclared allergen: "The dietary supplements have the potential to be contaminated with undeclared steroids, pharmaceutical ingredients and/or chemical additives due to lack of GMPs." Allergen mislabeling is the leading cause of U.S. food recalls, because a missing declaration can trigger a reaction in someone who reads the label and believes the product is safe.

The product reached multiple states, recorded by the FDA as "GA, FL, NC, possibly NJ and New Zealand." A multi-state footprint means the same lot can surface in households far from the producer. The recalling firm is based in Farmingdale, NY. The FDA has Terminated this recall (first reported Jan 8, 2014), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.